• Loading stock data...
PublicWire | Emerging Market Stock News
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
  •  Home
  • Technology
  • Medical
  • Energy
  • Cannabis
  • Finance
  • Retail
  • General
  • Podcast
  • Videos
  • Services
No Result
View All Result
PublicWire
No Result
View All Result

Home » Cannabis » Cannabis Stocks Drop After Conflicting Views On CBD Substance During FDA Hearing

Cannabis Stocks Drop After Conflicting Views On CBD Substance During FDA Hearing

Leean Vitudio by Leean Vitudio
June 4, 2019
in Cannabis, Medical
2 min read
62
0
Cannabis stocks fall after FDA hearing

Cannabis stocks fall monday after FDA hearing report

When investors read Friday’s report from the regulatory hearing of cannabis and its ingredients, cannabis stocks lowered last Monday upon the legalization of weed for adult recreational in Illinois.

The hearing ensued due to the commencement of selling and purchasing of hemp-based products both online and in mom-and-pop stores. Since CBD has been well-known because of its wellness properties, especially on treating pain, anxiety, and inflammation, it was not included on the federal ban. But still, it was placed on a regulatory purview due to its primary ingredient.

In a note to clients, Evercore ISI analysts led by Josh Schimmer said, “[the hearing] highlighted the messy state of the industry with the widespread use of CBD products with minimal standardization.”

Despite the discussion, GW Pharmaceuticals gained 1.1% in shares in the cannabis sector on Monday. This was when the FDA assured that it would continue clinical research on the substance.

Alliance Global Partners analyst Aaron Grey said that Illinois is the first state to achieve the legalization of cannabis that involved retail stores through legislative. He also cited that it can be a template for other states who seek the same such as New York, New Jersey, and Connecticut.

Added to that, Grey expects individual stocks such as KushCo Holdings to benefit from the news. He also eyes the Canadian, Canopy Growth Corp to advance — as they plan to acquire Acreage Holdings Inc. who has a medical license for Illinois. However, both shares of companies were down by 2.4% and 2%, respectively.

Elsewhere, Tilt Holdings Inc. was down 6.3%, Tilray Inc. dropped by 4.5%, Aurora Cannabis Inc. fell 2.7%, and Cronos Group Inc. was down 2.3%. Valens GroWorks Corp was down 4.7%, Organigram Holdings Inc was down 2.1%, and Aleafia Health Inc. was down 2.8%. Green Growth Brands Inc. was down 6.9%, Aphria Inc. fell 2.9%, and Green Organic Dutchman Holdings Inc. was down 1.2%.

Also, The Horizons Marijuana Life Sciences ETF fell 1.9%, and ETFMG Alternative Harvest ETF was down 1.7%. The Dow Jones Industrial Average was up 0.02%, and the S&P 500 was down 0.3%

Leean Vitudio

Leean Vitudio

Living a double life: marketing executive by day, writer at the dead of night.

Related Posts

Regeneron buy back shares from Sanofi
Medical

Regeneron to buy back $5 billion shares from Sanofi

May 25, 2020
132
A report reveals that China is deliberately faking the number of COVID-19 cases and deaths.
General

China is underreporting COVID-19 cases, U.S. intelligence community says

April 1, 2020
151
Around the world, the total number of confirmed coronavirus infection went beyond 600,000, with 28,964 fatalities as of the latest report.
Medical

17% of all confirmed COVID-19 cases in the world comes from the US

March 28, 2020
138
President Donald Trump signed a $2 trillion coronavirus relief bill on Friday
General

Trump signs $2 trillion coronavirus relief

March 28, 2020
121
General Motors and Ventec Life Systems are partnering to convert the GM Kokomo, Indiana ERC building for the production of Ventec ventilators in response to the COVID-19 pandemic.
General

GM announces the start of production of critical-care ventilators shortly after Trump’s tweets against CEO

March 27, 2020
132
Rep. Thomas Massie, R-Ky., tried to force a full yes or no vote on the measure, which could have delayed its passage by hours.
Finance

$2 trillion coronavirus stimulus package passed by the House amid efforts to delay voting by Massie

March 27, 2020
118
Currently Playing

Subscribe To Our Newsletter

Ad

PublicWire | Emerging Market Stock News 24/7 | Investor Relations US Stock Market

© Copyright 2020 PublicWire.com

Navigate Site

  • About
  • #96576 (no title)
  • Disclaimer
  • Watch LIVE
  • Privacy Policy
  • Terms and Services
  • Contributors

Follow Us

No Result
View All Result
  • LIVE Investor News Channel
  • Cannabis
  • Energy
  • Finance
  • General
  • Medical
  • Podcasts
  • Retail
  • Technology
  • #370 (no title)

© Copyright 2020 PublicWire.com

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Public Wire Logo

Hello please subscribe to our newsletter to get up to date news weekly!

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.